vorinostat has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigolon, G | 1 |
| Araldi, E | 1 |
| Erni, R | 1 |
| Wu, JY | 1 |
| Thomas, C | 1 |
| La Fortezza, M | 1 |
| Laube, B | 1 |
| Pöhlmann, D | 1 |
| Stoffel, M | 1 |
| Zarse, K | 1 |
| Carreira, EM | 1 |
| Ristow, M | 1 |
| Fischer, F | 1 |
1 other study available for vorinostat and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Grainyhead 1 acts as a drug-inducible conserved transcriptional regulator linked to insulin signaling and lifespan.
Topics: Animals; Animals, Genetically Modified; Blood Glucose; Caenorhabditis elegans; Caenorhabditis elegan | 2022 |